Clinical characteristics of stroke patients with antiphospholipid antibodies

Cerebrovascular Diseases

Volumn 19, Issue 6, 2005, Pages 384-390

  Terashi, Hiromi ^a   Uchiyama, Shinichiro ^a   Hashimoto, Shiori ^a   Miyazaki, Kazuhide ^a   Tsutsumi, Yukiko ^a   Yamazaki, Masako ^a   Iwata, Makoto ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Antiphospholipid syndrome; Cerebral infarction

Indexed keywords

PHOSPHOLIPID ANTIBODY; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; BRAIN INFARCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROKE; VALVULAR HEART DISEASE;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 21344464939     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085567     Document Type: Article

References (37)

1. Euro-Phospholipid Project Group: Antiphospholipid syndrome. Arthritis Rheum 2002;46:1019-1027.
2. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Hariss EN, Hughes GRV, Triplett DA, Khamashta MA: International consensus Statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-1311.
3. The Committee of Japan Diabetic Society for Diagnostic Criteria of Diabetes Mellitus: Report of the Committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus (in Japanese). J Jpn Diab Soc 1999;42:385-404.
4. Luong TH, Rand JH, Wu XX, Godbold JH, Gascon-Lema M, Tuhrim S: Seasonal distribution of antiphospholipid antibodies. Stroke 2001;32:1707-1711.
5. Kushner M: Prospective study of anticardiolipin antibodies in stroke. Stroke 1990;21:295-298.
6. Babazono Y: Clinical and hematological investigation of stroke patients with anticardiolipin antibodies (in Japanese). Jpn J Stroke 1991;14:272-278.
7. The Antiphospholipid Antibodies in Stroke Study (APASS) Group: Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993;43:2069-2073.
8. Tuhrim S, Rand JH, Wu XX, Weinberger J, Horowitz DR, Goldman ME, Godbold JH: Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Stroke 1999;30:1561-1565.
9. The Antiphospholipid Antibodies in Stroke Study (APASS) Group: Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990;21:1268-1273.
10. Levine SR, Deegan MJ, Futrell N, Welch KMA: Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990;40:1181-1189.
11. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D: Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189-193.
12. Meroni PL, Raschi E, Camera M, Testoni C, Nicoletti F, Tincani A, Khamashta MA, Balestrieri G, Tremoli E, Hess DC: Endothelial activation by aPL: A potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun 2000;15:237-240.
13. Roubey RAS: Tissue factor pathway and the antiphospholipid syndrome. J Autoimmun 2000;15:217-220.
14. Rand JH, Wu XX: Antibody-mediated disruption of annexin V antithrombotic shield: A new mechanism for thrombosis in the antiphospholipid syndrome. Thromb Haemost 1999;82:649-655.
15. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Soto AL, Tolosa C, Franz J, Selva A, Ingelmo M, Vilardell M, Hughes GRV: Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am J Med 1994;96:3-9.
16. Khamashta MA, Hughes GRV: Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995;7:389-394.
17. Hojnik M, George J, Ziporen L, Shoenfeld Y: Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93;1579-1587.
18. Galve E, Riera JC, Pigrau Castillo GD, Soler JS, Miralda GP: Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1998;319:817-823.
19. Atsumi T, Koike T: Cardiac valve disease and antiphospholipid syndrome. Intern Med 2000;39:446-447.
20. Mottram PM, Gelman JS: Mitral valve thrombus mimicking a primary tumor in the antiphospholipid syndrome. J Am Soc Echocardiogr 2002;15:746-748.
21. Rademacher J, Sohngen D, Specker C, Janda I, Sitzer M: Cerebral microembolism, a disease marker for ischemic cerebrovascular events in the antiphospholipid syndrome of systemic lupus erythematosus? Acta Neurol Scand 1999;99:356-361.
22. Chapman J, Rand JH, Brey RL, Levine SR, Blatt I, Khamashta MA, Shoenfeld Y: Non-stroke neurological syndromes associated with antiphospholipid antibodies: Evaluation of clinical and experimental studies. Lupus 2003;12:514-517.
23. Tsutsumi Y, Mochizuki A, Maruyama K, Uchiyama S, Iwata M: Myelopathy in patients with antiphospholipid antibodies: Clinical features, pathogenesis, and review of literature (in Japanese). Rinshoshikeigaku 2004;44:655-660.
24. Ozturk MA, Hazendaroglu IC, Turgut M, Goker H: Current debates in antiphospholipid syndrome: The acquired antibody-mediated thrombophilia. Thromb Haemost 2004;10:89-126.
25. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002;346:752-763.
26. Ames PRJ, Tommashino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V: Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies - A crucial role for acquired free protein S deficiency. Thromb Haemost 1996;76:190-194.
27. Uchiyama S, Yamazaki M, Hara Y, Iwata M: Alterations of platelet, coagulation, and fibrinolysis markers in patients with acute ischemic stroke. Semin Thromb Hemost 1997;23:535-541.
28. Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Ikeda T: Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994;71:424-427.
29. Ieko M: Antiphospholipid antibodies and thrombosis: The putative mechanisms of hypercoagulable state in patients with anticardiolipin antibody (in Japanese). Jpn J Clin Pathol 2000;48:293-300.
30. Naitoh S, Masahiro I, Takeda M, Atsumi T, Koike T: Evaluation of F1+2/TAT ratios in Japanese patients with antiphospholipid syndrome (in Japanese). Jpn J Clin Pathol 2000;48:540-546.
31. Shibata S, Harpel PC, Gharavi A, Rand J, Howard F: Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994; 83:2532-2540.
32. Best IM, Vansandani G, Rust G, Bumpers HL: Recurrent ischemia in a young man with the antiphospholipid syndrome. Am Surg 2002;68:598-602.
33. Feldmann E, Levine SR: Cerebrovascular disease with antiphospholipid antibodies: Immune mechanisms, significance, and therapeutic options. Ann Neurol 1995;37:s114-s129.
34. Kitagawa Y, Shinohara Y, Niwa K, Yoshitoshi M, Kametsu Y: Recurrence and prognosis in ischemic stroke patients with anticardiolipin antibody in Japan (in Japanese). Rinshoshinkeigaku 1994;34:799-804.
35. Wang HC, Tu HC, Choi WM: Ischemic stroke in a teenage girl with primary antiphopholipid antibody syndrome. J Formos Med Assoc 2000;99:62-65.
36. Schutt M, Wiedemann GJ, Seidel G, Neusch C, Vieregge P, Kluter H: Ischemic stroke due to transient thrombosis of the internal carotid artery in a patient with combined antiphospholipid syndrome and factor V Leiden. Am J Med 1999;107:527-528.
37. Ames PRJ: Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: A unifying 'membrane stress syndrome' hypothesis. Lupus 1994;3:371-377.